• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    athero.pdf
    Size:
    703.4Kb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Iqbal, Z.
    Ho, J. H.
    Adam, Safwaan
    France, M.
    Syed, A.
    Neely, D.
    Rees, A.
    Khatib, R.
    Cegla, J.
    Byrne, C.
    Qureshi, N.
    Capps, N.
    Ferns, G.
    Payne, J.
    Schofield, J.
    Nicholson, K.
    Datta, D.
    Pottle, A.
    Halcox, J.
    Krentz, A.
    Durrington, P.
    Soran, H.
    Show allShow less
    Affiliation
    Cardiovascular Trials Unit, Manchester University NHS Foundation Trust, Manchester, United Kingdom; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
    Issue Date
    2020
    
    Metadata
    Show full item record
    Abstract
    The emergence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes Coronavirus Disease 2019 (COVID-19) has resulted in a pandemic. SARS-CoV-2 is highly contagious and its severity highly variable. The fatality rate is unpredictable but is amplified by several factors including advancing age, atherosclerotic cardiovascular disease, diabetes mellitus, hypertension and obesity. A large proportion of patients with these conditions are treated with lipid lowering medication and questions regarding the safety of continuing lipid-lowering medication in patients infected with COVID-19 have arisen. Some have suggested they may exacerbate their condition. It is important to consider known interactions with lipid-lowering agents and with specific therapies for COVID-19. This statement aims to collate current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19. We offer a consensus view based on current knowledge and we rated the strength and level of evidence for these recommendations. Pubmed, Google scholar and Web of Science were searched extensively for articles using search terms: SARS-CoV-2, COVID-19, coronavirus, Lipids, Statin, Fibrates, Ezetimibe, PCSK9 monoclonal antibodies, nicotinic acid, bile acid sequestrants, nutraceuticals, red yeast rice, Omega-3-Fatty acids, Lomitapide, hypercholesterolaemia, dyslipidaemia and Volanesorsen. There is no evidence currently that lipid lowering therapy is unsafe in patients with COVID-19 infection. Lipid-lowering therapy should not be interrupted because of the pandemic or in patients at increased risk of COVID-19 infection. In patients with confirmed COVID-19, care should be taken to avoid drug interactions, between lipid-lowering medications and drugs that may be used to treat COVID-19, especially in patients with abnormalities in liver function tests.
    Citation
    Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, et al. Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. Atherosclerosis. 2020;313:126-36.
    Journal
    Atherosclerosis
    URI
    http://hdl.handle.net/10541/623393
    DOI
    10.1016/j.atherosclerosis.2020.09.008
    PubMed ID
    33045618
    Additional Links
    https://dx.doi.org/10.1016/j.atherosclerosis.2020.09.008
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.atherosclerosis.2020.09.008
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • [Lipid treatment in the period COVID-19].
    • Authors: Frías Vargas M, Díaz Rodríguez A, Díaz Fernández B
    • Issue date: 2020 Oct
    • Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic.
    • Authors: Banach M, Penson PE, Fras Z, Vrablik M, Pella D, Reiner Ž, Nabavi SM, Sahebkar A, Kayikcioglu M, Daccord M, FH Europe and the International Lipid Expert Panel (ILEP)
    • Issue date: 2020 Aug
    • Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement.
    • Authors: Malek M, Hosseinpanah F, Aghaei Meybodi HR, Jahed SA, Hadaegh F, Sharghi S, Esteghamati A, Khamseh ME
    • Issue date: 2020 Aug 1
    • COVID-19 and the liver: What do we know after six months of the pandemic?
    • Authors: Fierro NA
    • Issue date: 2020 Nov-Dec
    • COVID-19 and diabetes: No time to drag our feet during an untimely pandemic.
    • Authors: Kyrou I, Robbins T, Randeva HS
    • Issue date: 2020 Sep
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.